.Pharmacolibrary.Drugs.N_NervousSystem.N04B_DopaminergicAgents.N04BC01_Bromocriptine.Bromocriptine .Pharmacolibrary.Drugs.N_NervousSystem.N04B_DopaminergicAgents.N04BC01_Bromocriptine.Bromocriptine| name: | Bromocriptine | |
| ATC code: | N04BC01 | route: | oral |
| compartments: | 2 | |
| dosage: | 5 | mg |
| volume of distribution: | 95 | L |
| clearance: | 5.1 | L/h |
| other parameters in model implementation | ||
Bromocriptine is a dopamine D2 receptor agonist derived from ergot, mainly used for the treatment of Parkinson’s disease, hyperprolactinemia, acromegaly, and type 2 diabetes. It is approved and currently used in clinical practice for these indications.
Pharmacokinetic parameters reported in healthy adult volunteers (both male and female) after single oral doses.